# COVID-19 Infection

> **NCT05926076** · — · UNKNOWN · sponsor: **Tianjin First Central Hospital** · enrollment: 610 (estimated)

## Conditions studied

- COVID-19
- Renal Transplant Infection

## Interventions

- **OTHER:** Treatment plan

## Key facts

- **NCT ID:** NCT05926076
- **Lead sponsor:** Tianjin First Central Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-25
- **Primary completion:** 2023-07-30
- **Final completion:** 2023-07-30
- **Target enrollment:** 610 (ESTIMATED)
- **Last updated:** 2023-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05926076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05926076, "COVID-19 Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05926076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*